P Sinha1, A P Moll2, R P Brooks1, Y-H Deng3, S V Shenoi1. 1. Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, USA. 2. Church of Scotland Hospital, ARV Programme, Tugela Ferry, South Africa. 3. Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, Connecticut, USA.
Abstract
SETTING: Community health screenings in KwaZulu-Natal Province, South Africa. OBJECTIVE: To study the synergism between diabetes mellitus (DM) and human immunodeficiency virus (HIV) infection in increasing the risk of tuberculosis (TB). DESIGN: In this cross-sectional study, we analyzed data from two community health projects, one at congregate settings, and one at household settings (n = 7708), in a rural resource-limited region where integrated communicable and non-communicable disease screening services were offered. Odds ratios (ORs) for demographic factors, socio-economic factors, DM status, and HIV positivity were calculated using multivariate analysis, and the statistical interaction between HIV and DM was tested. The primary outcome was the presence of TB symptoms. RESULTS: Among 7708 individuals, age >65 years (OR 1.72, 95%CI 1.47-2.02), HIV infection (OR 1.66, 95%CI 1.40-1.97) and DM (OR 1.36, 95%CI 1.11-1.67) were independently associated with increased odds of TB symptoms. Receiving monthly grants (OR 0.78, 95%CI 0.66-0.91), access to a toilet (OR 0.54, 95%CI 0.35-0.83), and access to solar or electric energy (OR 0.86, 95%CI 0.77-0.97) reduced the odds. There was evidence of significant interaction between DM and HIV on the multiplicative scale. CONCLUSION: DM and HIV synergistically increased the odds of TB symptoms according to these retrospective data. Future studies should prospectively evaluate synergism between HIV and DM in increasing the risk of active TB.
SETTING: Community health screenings in KwaZulu-Natal Province, South Africa. OBJECTIVE: To study the synergism between diabetes mellitus (DM) and human immunodeficiency virus (HIV) infection in increasing the risk of tuberculosis (TB). DESIGN: In this cross-sectional study, we analyzed data from two community health projects, one at congregate settings, and one at household settings (n = 7708), in a rural resource-limited region where integrated communicable and non-communicable disease screening services were offered. Odds ratios (ORs) for demographic factors, socio-economic factors, DM status, and HIV positivity were calculated using multivariate analysis, and the statistical interaction between HIV and DM was tested. The primary outcome was the presence of TB symptoms. RESULTS: Among 7708 individuals, age >65 years (OR 1.72, 95%CI 1.47-2.02), HIV infection (OR 1.66, 95%CI 1.40-1.97) and DM (OR 1.36, 95%CI 1.11-1.67) were independently associated with increased odds of TB symptoms. Receiving monthly grants (OR 0.78, 95%CI 0.66-0.91), access to a toilet (OR 0.54, 95%CI 0.35-0.83), and access to solar or electric energy (OR 0.86, 95%CI 0.77-0.97) reduced the odds. There was evidence of significant interaction between DM and HIV on the multiplicative scale. CONCLUSION:DM and HIV synergistically increased the odds of TB symptoms according to these retrospective data. Future studies should prospectively evaluate synergism between HIV and DM in increasing the risk of active TB.
Authors: S W Park; J W Shin; J Y Kim; I W Park; B W Choi; J C Choi; Y S Kim Journal: Eur J Clin Microbiol Infect Dis Date: 2011-10-25 Impact factor: 3.267
Authors: Christie Y Jeon; Anthony D Harries; Meghan A Baker; Jessica E Hart; Anil Kapur; Knut Lönnroth; Salah-Eddine Ottmani; Sunali Goonesekera; Megan B Murray Journal: Trop Med Int Health Date: 2010-09-24 Impact factor: 2.622
Authors: Catherine R Stevenson; Julia A Critchley; Nita G Forouhi; Gojka Roglic; Brian G Williams; Christopher Dye; Nigel C Unwin Journal: Chronic Illn Date: 2007-09
Authors: Daniel Faurholt-Jepsen; Nyagosya Range; George Praygod; Kidola Jeremiah; Maria Faurholt-Jepsen; Martine Grosos Aabye; John Changalucha; Dirk Lund Christensen; Christian Bressen Pipper; Henrik Krarup; Daniel Rinse Witte; Aase Bengaard Andersen; Henrik Friis Journal: PLoS One Date: 2011-08-30 Impact factor: 3.240
Authors: Jennifer A Gilbert; Sheela V Shenoi; Anthony P Moll; Gerald H Friedland; A David Paltiel; Alison P Galvani Journal: PLoS One Date: 2016-12-01 Impact factor: 3.240
Authors: Klauss Villalva-Serra; Beatriz Barreto-Duarte; Vanessa M Nunes; Rodrigo C Menezes; Moreno M S Rodrigues; Artur T L Queiroz; María B Arriaga; Marcelo Cordeiro-Santos; Afrânio L Kritski; Timothy R Sterling; Mariana Araújo-Pereira; Bruno B Andrade Journal: Front Med (Lausanne) Date: 2022-09-16